共 164 条
[1]
Hazekamp A(2013)The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms J Psychoactive Drugs 45 199-210
[2]
Ware MA(2019)The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia Brain, Behav Immun 77 110-126
[3]
Muller-Vahl KR(2019)Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand? Drug Discov Today 24 1845-1853
[4]
Abrams D(2021)Immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review J Neuroimmune Pharmacol 16 251-269
[5]
Grotenhermen F(2021)The effect of cannabis on the clinical and cytokine profiles in patients with multiple sclerosis Multiple Sclerosis Int 2021 6611897-6
[6]
Mecha M(2018)Medical use of cannabis and cannabinoids containing products - regulations in Europe and North America Eur J Intern Med 49 2-454
[7]
Yanguas-Casás N(2018)Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: a survey of the status in the chapters of the European Pain Federation Eur J Pain 22 440-47
[8]
Feliú A(2019)Cannabis and cannabinoids for people with multiple sclerosis [Protocol] Cochrane Database of Systematic Reviews 2019 CD013444-6
[9]
Mestre L(2009)Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study Clin Neuropharmacol 32 41-459
[10]
Carrillo-Salinas F(2007)Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis Eur J Neurol 14 290-1150